Shandong Buchang Pharmaceuticals Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 7,035.453 million compared to CNY 6,404.750 million a year ago. Operating income was CNY 1,093.337 million compared to CNY 1,094.699 million a year ago. Net income was CNY 901.511 million compared to CNY 798.790 million a year ago. Basic earnings per share from continuing operations was CNY 0.8151 compared to CNY 0.7098 a year ago.